V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003495 | 210011687 | 1.63 | null | null | 2019-11-04 | 2020-02-16 | ATEZOLIZUMAB + NAB PACLITAXEL | null | null | PACLITAXEL + TRASTUZUMAB | 100170841 |
| 210003501 | 210011690 | 1.42 | 66.2 | null | 2018-12-29 | 2019-01-05 | Capecitabine | null | null | CAPECITABINE | 101043228 |
| 210003502 | 210011691 | null | 83.1 | null | 2018-07-05 | 2018-07-08 | Paclitaxel+Trastuzumab wkly Maint | 02 | null | PACLITAXEL + TRASTUZUMAB | 100410458 |
| 210003504 | 210011692 | 1.72 | 56 | Palliative (P) | 2018-05-25 | 2018-05-27 | FEC 100 | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101572966 |
| 210003511 | 210011694 | 1.64 | 76.2 | Adjuvant (A) | 2017-12-04 | 2017-12-20 | Paclitaxel+Trastuzumab wkly Maint | null | N | PACLITAXEL + TRASTUZUMAB | 101358189 |
| 210003512 | 210011695 | 0 | 63 | null | 2019-06-11 | 2019-09-18 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101860377 |
| 210003513 | 210011696 | 1.75 | 73 | null | null | 2019-01-17 | Neratinib | 02 | null | NERATINIB | 101334842 |
| 210003515 | 210011697 | 1.56 | 84.9 | Neo-adjuvant (N) | 2018-10-29 | 2018-11-07 | FEC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100708990 |
| 210003517 | 210011698 | 1.68 | 53.8 | Adjuvant (A) | 2022-01-28 | 2022-04-24 | FEC | 02 | N | TRIAL UNSPECIFIED | 100215560 |
| 210003521 | 210011699 | 1.65 | 75 | Neo-adjuvant (N) | null | 2021-01-10 | VINORELBINE | 02 | null | VINORELBINE | 100132424 |
| 210003523 | 210011700 | 0 | 88.7 | Palliative (P) | 2015-08-09 | 2019-12-27 | null | 02 | N | EC | 101699740 |
| 210003533 | 210011703 | 1.66 | 82 | Palliative (P) | 2017-07-13 | 2017-07-20 | null | 02 | N | EC | 100241636 |
| 210003538 | 210011706 | 1.69 | null | Adjuvant (A) | 2018-03-11 | 2018-03-12 | null | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101613746 |
| 210003540 | 210011708 | 1.64 | 91.6 | null | 2019-11-12 | 2019-11-20 | Palbociclib | 02 | null | CARBOPLATIN + PACLITAXEL | 100590453 |
| 210003545 | 210011712 | 1.66 | 97.5 | null | 2022-01-13 | 2022-01-23 | Capecitabine | 02 | null | CAPECITABINE | 100652043 |
| 210003556 | 210011715 | null | 76.5 | Palliative (P) | null | 2017-06-14 | Letrozole + Palbociclib | 02 | N | ABEMACICLIB + FULVESTRANT | 100530539 |
| 210003561 | 210011717 | 1.63 | 54.4 | null | 2017-03-29 | 2017-03-29 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100160981 |
| 210003562 | 210011718 | 1.58 | 118 | null | 2019-12-03 | 2019-12-03 | null | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL + TRASTUZUMAB | 101857054 |
| 210003564 | 210011719 | 1.63 | 68.4 | null | 2021-06-01 | 2021-06-14 | Eribulin | 02 | null | ERIBULIN | 100430523 |
| 210003566 | 210011721 | 1.63 | 71.5 | null | 2018-08-13 | 2018-12-11 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101128317 |
| 210003570 | 210011722 | 0 | 105.6 | null | null | 2020-01-11 | Capecitabine | 02 | null | CAPECITABINE | 100160946 |
| 210003572 | 210011724 | 1.75 | 60.6 | Curative (C) | null | 2018-06-19 | null | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101700148 |
| 210003580 | 210011726 | 1.48 | 76.9 | null | 2019-09-22 | 2020-01-10 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101198518 |
| 210003581 | 210011727 | 1.51 | 106.45 | Palliative (P) | 2020-12-20 | 2020-12-26 | Capecitabine | 02 | N | CAPECITABINE | 100435926 |
| 210003589 | 210011730 | null | null | Palliative (P) | 2019-04-18 | 2019-04-26 | TCH (21 day Trastuzumab) Maint | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN | 100863282 |
| 210003593 | 210011732 | 1.67 | 73.6 | null | 2016-11-30 | 2016-12-10 | null | 02 | null | ROSCO TRIAL | 101634886 |
| 210003596 | 210011734 | 1.54 | 106.4 | null | 2017-04-28 | 2017-07-22 | null | 02 | null | EC | 100932729 |
| 210003609 | 210011740 | 1.59 | 0 | Palliative (P) | 2020-03-26 | 2020-04-14 | ATEZOLIZUMAB + NAB PACLITAXEL | null | N | TRIAL UNSPECIFIED | 101869396 |
| 210003610 | 210011741 | 1.62 | 58 | null | 2018-10-10 | 2018-10-17 | Trial Unspecified | 02 | null | CARBOPLATIN + DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 101694091 |
| 210003613 | 210011744 | 1.53 | 72 | Neo-adjuvant (N) | null | 2018-01-15 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100164255 |
| 210003614 | 210011745 | 1.63 | 55.75 | null | null | 2019-07-10 | FEC 100 | 02 | null | EPIRUBICIN | 100051436 |
| 210003619 | 210011747 | 1.7 | 65 | Neo-adjuvant (N) | 2018-07-29 | 2018-07-29 | TRASTUZUMAB EMTANSINE | 02 | N | LETROZOLE + PALBOCICLIB | 100762088 |
| 210003620 | 210011748 | 1.57 | 82.5 | Adjuvant (A) | null | 2020-04-28 | FEC | 02 | N | LETROZOLE + PALBOCICLIB | 101692920 |
| 210003622 | 210011749 | 1.56 | 64.3 | Palliative (P) | 2018-12-19 | 2018-12-21 | EC | 02 | N | EC | 100628901 |
| 210003627 | 210011750 | 1.59 | 82 | Palliative (P) | null | 2019-10-06 | Neratinib | 02 | null | NERATINIB | 101068345 |
| 210003633 | 210011753 | 1.69 | 69.8 | Adjuvant (A) | 2017-09-08 | 2017-09-08 | null | null | N | LETROZOLE + PALBOCICLIB | 100306543 |
| 210003635 | 210011755 | 1.58 | 104 | Palliative (P) | null | 2016-04-07 | GEMCARBO | null | N | CARBOPLATIN + GEMCITABINE | 101110095 |
| 210003640 | 210011758 | 1.58 | 74.4 | Adjuvant (A) | null | 2019-10-24 | FEC 100 | 01 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100230306 |
| 210003641 | 210011759 | 1.62 | 75.9 | null | 2019-11-15 | 2019-11-27 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | null | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100075897 |
| 210003643 | 210011760 | 1.63 | null | null | 2021-03-19 | 2021-05-05 | Carboplatin + Docetaxel | null | null | ROSCO TRIAL | 101860198 |
| 210003646 | 210011762 | 1.54 | 91.4 | null | 2017-09-30 | 2017-10-13 | Capecitabine | 02 | null | CAPECITABINE | 100777280 |
| 210003648 | 210011764 | null | null | null | 2018-05-16 | 2018-08-12 | Eribulin | null | null | ERIBULIN | 100213352 |
| 210003655 | 210011768 | 1.55 | 65.4 | Adjuvant (A) | null | 2020-02-10 | null | 01 | null | CARBOPLATIN + PACLITAXEL | 100450128 |
| 210003661 | 210011769 | 1.85 | 68.1 | Palliative (P) | null | 2020-08-21 | CARBOPLATIN + GEMCITABINE | 02 | N | CARBOPLATIN + GEMCITABINE | 101142984 |
| 210003663 | 210011771 | 1.68 | 55.5 | null | 2016-09-30 | 2018-08-26 | Vinorelbine (oral) | 02 | null | VINORELBINE | 100137596 |
| 210003667 | 210011772 | 1.81 | 0 | Neo-adjuvant (N) | 2020-11-07 | 2020-12-11 | Capecitabine | 02 | N | CAPECITABINE | 100691223 |
| 210003673 | 210011776 | 1.79 | 151 | Palliative (P) | null | 2017-03-13 | Neratinib | 02 | N | NERATINIB | 100881847 |
| 210003675 | 210011777 | 1.54 | 82.5 | 03 | 2017-02-12 | 2017-02-18 | Paclitaxel+Trastuzumab wkly Maint | 02 | N | PACLITAXEL + TRASTUZUMAB | 100967742 |
| 210003678 | 210011780 | 1.68 | 87.5 | Adjuvant (A) | 2016-08-02 | 2016-08-08 | Capecitabine | 02 | N | CAPECITABINE | 100035580 |
| 210003679 | 210011781 | null | null | null | null | 2018-08-04 | Letrozole + Palbociclib | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101863233 |